Abstract: Neutrophils possess a very short lifespan, dying by apoptosis. HL-60 cells undergo apoptosis after neutrophil differentiation with dimethyl sulfoxide (DMSO). We have found that the onset of apoptosis in neutrophil-differentiating HL-60 cells correlates with the achievement of an apoptosis-related gene expression pattern similar to that of peripheral blood mature neutrophils. Using reverse transcriptase-polymerase chain reaction, cloning, and sequencing techniques, we have found that HL-60 cells express bak, bik, bax, bad, bcl-2, bcl-x L , bcl-w, bfl-1, fas, and caspases 1-4 and 7-10. After DMSO treatment, bak, bcl-w, bfl-1, fas, and caspases 1 and 9 were up-regulated, whereas bik, bcl-2, and caspases 2, 3, and 10 were down-regulated at different degrees, achieving mRNA expression levels that correlated with those detected in peripheral blood neutrophils. Caspase-2 mRNA and protein expression was drastically reduced after HL-60 cell differentiation, being absent in both HL-60-differentiated neutrophils and mature neutrophils, whereas caspase-3 and -10 mRNA and protein expression were diminished upon HL-60 cell differentiation until achieving the respective levels found in mature neutrophils. Bak and bfl-1 mRNA levels were largely increased during DMSO-induced differentiation of HL-60 cells, and these genes were the bcl-2 family members that were expressed most abundantly in mature neutrophils. Bcl-2 overexpression or caspase inhibition prevented differentiation-induced apoptosis in HL-60 cells, but not their differentiation capability. Neutrophil spontaneous apoptosis was also blocked by the caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone. Peripheral blood neutrophils expressed bak, bad, bcl-w, bfl-1, fas, and caspases 1, 3, 4, and 7-10, but hardly expressed bcl-2, bcl-x L , bik, bax, and caspase-2. These results suggest that the above gene expression changes in neutrophil-differentiating HL-60 cells may play a role in the acquisition of the neutrophil apoptotic features. J. Leukoc. Biol. 67: 712-724; 2000.
INTRODUCTION
Neutrophils play a major role in the host defenses against the invasion of microorganisms and in acute inflammation and have been implicated in the pathogenesis of a number of human diseases [1] . About ten million new neutrophils are produced and released into the bloodstream from the bone marrow every minute in the average adult [2] . However, the number of circulating neutrophils remains constant, indicating that an equivalent number of neutrophils must be deleted continuously to maintain a proper balance of neutrophils in peripheral blood. Neutrophils enter the bloodstream and tissues as terminally differentiated cells, which are unable to self-renew and have the shortest half-life of all circulating leukocytes. After leaving the bone marrow, neutrophils are programmed to die within about 24 h as a result of constitutive and spontaneous apoptosis [3] [4] [5] , a controlled biological process leading to the physiological death of the cell, and characterized by cell shrinkage, chromatin condensation, and internucleosomal DNA degradation, widely considered to be a biochemical hallmark of apoptosis [6] .
Accumulating evidence indicates that the Fas (APO-1; CD95)/Fas ligand (FasL) system represents an important cellular pathway responsible for the induction of apoptosis in a wide variety of tissues. Fas is a widely expressed 45-kDa type I membrane protein member of the tumor necrosis factor (TNF)/ nerve growth factor receptor superfamily, which mediates apoptosis [7] [8] [9] [10] [11] . Fas is activated to induce apoptosis after interaction with agonistic anti-Fas IgM antibodies or with its natural ligand FasL, a 40-kDa type II protein member of the TNF family [9, 10, 12, 13] . In contrast to Fas, constitutive expression of FasL is relatively restricted in its tissue distribution [9] [10] [11] , but it can be induced under different experimental conditions in several cell types [14] [15] [16] [17] . After programmed cell death is triggered, the process of apoptosis is mainly regulated by different members of two growing gene families, namely Bcl-2-related genes and caspases, as well as Apaf-1. Since the initial identification of the bcl-2 gene as a proto-oncogene deregulated in t(14;18)-bearing B cell lymphomas [18] , several homologous proteins have subsequently been identified that comprise the growing Bcl-2 protein family. Some members of this Bcl-2 protein family inhibit apoptosis (Bcl-2, Bcl-x L , Bcl-w, Bfl-1) and others promote apoptosis (Bax, Bak, Bik, Bad, Bcl-x s ) [19] [20] [21] [22] . The so-called caspase family includes a growing family of at least 14 cysteine proteases showing homology with the mammalian protein interleukin-1␤-converting enzyme (ICE) and exerting an effector function in programmed cell death [23, 24] . The name caspase for these ICE-like proteases was selected to indicate two catalytic properties of these enzymes: the ''c'' denoting a cysteine protease, and the ''aspase'' referring to their ability to cleave after an aspartic residue [25] .
The human promyelocytic HL-60 cell line has been widely used as a cell culture model of human neutrophils [26] [27] [28] . HL-60 cells can be induced to differentiate toward cells sharing several functional features of mature neutrophils and, like neutrophils, die through spontaneous apoptosis after acquiring the biochemical and functional properties of mature neutrophils [28, 29] . Thus, HL-60 cells are a good model to study the apoptotic processes involved in neutrophil programmed cell death. A hallmark of neutrophil physiology is their rapid and spontaneous programming for cell death [4, 30] . It is well known that apoptosis is the major mechanism for limiting the neutrophil content in vivo, and seems to play an important role in the clearance of neutrophils from inflamed tissues by tissue macrophages, which is critical in the limitation of inflammatory tissue injury and in the subsequent resolution of inflammation [3, 30, 31] . However, transgenic mice that expressed bcl-2 in mature neutrophils showed that Bcl-2 blocked apoptosis of neutrophils, but not their engulfment by macrophages [32] . This suggests that the mechanism that triggers phagocytosis of aging neutrophils operates independently of the process of apoptosis regulated by Bcl-2, and that aging neutrophils exhibit cellsurface changes that allow them to be recognized and engulfed by macrophages independently of the apoptotic phases regulated by Bcl-2. Most inflammatory mediators and neutrophil activators [such as granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), and lipopolysaccharide (LPS)] prolong the functional lifespan of neutrophils through modulation of apoptosis [30, 31, [33] [34] [35] . However, the molecular mechanisms and constituents controlling neutrophil apoptosis remain largely unknown. The Fas/FasL system seems to represent a key mechanism controlling the rapid spontaneous turnover of neutrophils after their release from the bone marrow. Mature neutrophils are highly susceptible to Fas-induced death [36, 37] and co-express constitutively Fas and FasL in their cell membrane [37, 38] . Spontaneous neutrophil death in vitro was partially suppressed by Fas-Ig fusion protein or antagonistic anti-Fas IgG1 (ZB4 monoclonal antibody) [37] . This partial, but not complete, inhibition of neutrophil death indicates that the Fas/FasL pathway is an important, but not exclusive, mechanism involved in the regulation of spontaneous neutrophil apoptosis. This suggests that redundant mechanisms exist to ensure neutrophil apoptosis. Mature neutrophils are essentially absent for bcl-2 expression [36] . HL-60 cells express bcl-2, but induction of HL-60 differentiation toward the granulocytic pathway is accompanied by a marked decrease in bcl-2 mRNA and protein levels [39] [40] [41] . In this report, we examine the expression of a wide number of Bcl-2 and caspase family members in mature neutrophils and during differentiation of HL-60 cells toward the neutrophil lineage. We show that mature neutrophils and HL-60 cells differentiated toward neutrophils (HL-60 neutrophils) with dimethyl sulfoxide (DMSO) share characteristic and very similar patterns of expression of genes involved in the initiation, regulation, and execution of apoptosis. Here, we show a number of marked changes in apoptosisrelated genes during HL-60 cell differentiation toward the neutrophil lineage, which correlate with the appearance of the neutrophil apoptotic features. The importance of both bcl-2 and caspase gene families in the onset of mature neutrophil or HL-60 neutrophil apoptosis is highlighted by its prevention by caspase inhibition as well as by Bcl-2 overexpression. The similar constitutive and acquired apoptosis-related gene expression patterns shown by mature neutrophils and HL-60 neutrophils, respectively, seem to account for the short lifespan of both physiological peripheral blood neutrophils and cell culture model HL-60 neutrophils.
MATERIALS AND METHODS

Chemicals and reagents
RPMI 1640, fetal calf serum, antibiotics, L-glutamine, and TRIZOL reagent were purchased from GIBCO BRL (Grand Island, NY). Nitroblue tetrazolium (NBT) was from Sigma Chemical (St. Louis, MO). The anti-CD11b monoclonal antibody Bear 1 [42] was generously provided by Dr. J. E. De Vries (Unicet, Lyon, France). The anti-CD71 monoclonal antibody [43] and the P3X63 myeloma culture supernatant, used as a negative control, were kindly provided by Dr. F. Sánchez-Madrid (Hospital de la Princesa, Madrid, Spain). Mouse monoclonal IgG1 anti-caspase-2 antibody, and rabbit polyclonal anti-caspase-3 and anti-caspase-10 antibodies were from PharMingen (San Diego, CA). Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulin was from Dakopatts (Glostrup, Denmark). Ficoll-Paque was from Pharmacia LKB Biotechnology (Uppsala, Sweden). M-MLV reverse transcriptase was from Promega (Madison, WI). Taq DNA polymerase was from ECOGEN (Barcelona, Spain). DMSO was from Merck (Darmstadt, Germany). The caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone was from Alexis (Läufelfingen, Switzerland). All other chemicals were from Merck or Sigma.
Cells and culture conditions
The human leukemic cell lines HL-60 (acute myeloid leukemia) and NB4 (promyelocytic leukemia) were grown in RPMI 1640 culture medium supplemented with 10% (vol/vol) heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 units/mL penicillin, and 24 µg/mL gentamicin. HL-60 cells transfected with the SFFV-Neo expression vector containing the human bcl-2 open reading frame (HL-60-Bcl-2) and with empty SFFV-Neo plasmid (HL-60-Neo), kindly provided by Dr. J. L. Fernandez-Luna and Dr. A. Benito [41] , were grown as above in RPMI 1640 cell culture medium containing 10% (vol/vol) heatinactivated fetal calf serum and 1 mg/mL G418. Cells were incubated at 37°C in a humidified atmosphere of air/CO 2 (19/1). Neutrophil differentiation of HL-60 cells was induced by treatment with 1.3% (vol/vol) DMSO for the days indicated in the respective figures. The caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone (50 µM) was added 1 h before DMSO addition and every 48 h during DMSO incubation of HL-60 cells.
Human neutrophils were obtained from fresh heparinized peripheral blood obtained from healthy volunteers. Neutrophils were isolated by dextran sedimentation and centrifugation on Ficoll-Paque (Pharmacia LKB Biotechnology), followed by hypotonic lysis of residual erythrocytes [44] . The final cell preparation contained more than 99% neutrophils, as assessed by MayGrü nwald-Giemsa staining. Cell viability was evaluated by trypan blue dye exclusion and was always higher than 99%.
Morphological assessment of neutrophil apoptosis
About 2 ϫ 10 5 neutrophils in 200 µL were cytospun at 1,000 rpm for 2 min (cytospin 3, Shandon Scientific, Cheshire, UK). Cells were then air-dried briefly and May-Grü nwald-Giemsa-stained with a commercial kit from Merck. Apoptotic cells were identified by characteristic chromatin condensation and cytoplasmic vacuolization.
Visualization of DNA fragmentation by agarose gels
To analyze apoptosis, we isolated fragmented DNA as described [28, 45] . Briefly, 2 ϫ 10 6 cells were washed with phosphate-buffered saline (PBS) and then lysed with 200 µL hypotonic detergent buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 0.2% Triton X-100) for 30 min at 4°C. Nuclear and subcellular organelles were removed by centrifugation in a microfuge for 20 min, and the supernatant, containing the DNA released into the cytosol due to DNA fragmentation was incubated with RNase A (300 µg/mL) for 45 min at 37°C, and then with 200 µg/mL proteinase K in the presence of 0.5% (w/v) SDS for an additional 45 min at 37°C. Then the DNA was extracted, precipitated, and analyzed by electrophoresis on 1% (w/v) agarose gels as described previously [28, 45] . DNA was visualized after electrophoresis by ethidium bromide staining.
Analysis of DNA fragmentation by flow cytometry
Neutrophils (5 ϫ 10 5 ) were centrifuged and fixed overnight in 70% ethanol at 4°C. Then, cells were washed three times with PBS and incubated for 1 h with 1 mg/mL RNase A and 20 µg/mL propidium iodide at room temperature. Cells were then analyzed for cell cycle with a Becton Dickinson (San Jose, CA) FACScan flow cytometer. The induction of apoptosis was monitored as the appearance of a sub-G 1 /G 0 peak (hypodiploidy) in cell cycle analysis.
Analysis of cell-surface antigens by immunofluorescence flow cytometry
The cell-surface expression of CD11b and CD71 antigens was analyzed by immunofluorescence flow cytometry analysis in a FACScan flow cytometer (Becton Dickinson) as previously described [28, 46] . Fluorescence data were collected in log scale. Results were shown as percentages of positive cells for each antigen; cells incubated with P3X63 myeloma culture supernatant were used as a negative control.
NBT reduction
Respiratory burst activity was measured by NBT reduction as described previously [28] . Cells were stimulated with 50 ng/mL phorbol myristate acetate (PMA) for 15 min at 37°C in the presence of 0.1% (w/v) NBT followed by centrifugation, washing (70% methanol), and addition of 2 M KOH to lyse the cells, and DMSO to dissolve the formazan blue pellet. NBT reduction was quantified by the difference in the absorbencies at 620 and 450 nm as described previously [28] .
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from human neutrophils and cell lines according to the protocol of Chomczynski and Sacchi [47] or using TRIZOL reagent (GIBCO BRL) following the manufacturer's instructions. RNA preparations were carefully checked by gel electrophoresis and found to be free of DNA contamination. For the RT reaction, total RNA (3 µg) was primed with oligo(dT) and reverse-transcribed into cDNA with 30 units of M-MLV reverse transcriptase from Promega, according to manufacturer's instructions, in a final volume of 20 µL. The mixture was incubated at 37°C for 2 h. The generated cDNA was used for the semiquantitative RT-PCR analysis to assess mRNA expression as previously described [48] , and the ␤-actin gene was used as an internal control. A 25-µL PCR mixture contained 1 µL of the RT reaction, 10 . The conditions for PCR amplification of cDNA were as follows: one cycle at 95°C for 5 min as an initial denaturation step; then, denaturation at 95°C for 30 s, annealing for 30 s, and extension at 72°C for 90 s (the number of cycles was 26 to 30, depending on the linear range); followed by further incubation for 15 min at 72°C (one cycle). The annealing step was carried out at 60°C (bcl-w, caspase-1, caspase-5, caspase-6); 64°C (caspase-3), 65°C (bik, caspase-6, fas), 66°C (bfl-1), 67°C (caspase-7), or 69°C (bax, bak, bcl-x L , bad, caspase-2, caspase-4, caspase-8, caspase-9, caspase-10, and fasL). These experimental conditions were shown to be at the linear phase of amplification for each gene. In some cases, we performed PCR reactions using a higher number of cycles in order to assess the expression of a specific gene as indicated in the respective figure legend. After amplification, an aliquot of the PCR reaction was size fractionated onto a 2% agarose gel in 1ϫ TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0) and checked for the expected PCR products. Using the above-described primers, the expected sizes of PCR products for each gene were as follows: 
cDNA cloning and sequencing
The PCR products were directly cloned into the pCR 2.1 vector using the TA cloning kit (InVitrogen, San Diego, CA) following the manufacturer's indications. DNA sequencing was performed by thermal cycle sequencing with a Cy5 AutoCycle sequencing kit (Pharmacia LKB Biotechnology) and by automated laser fluorescent DNA sequencing (Pharmacia LKB Biotechnology) as well as with a PE Applied Biosystems 377 DNA sequencer (Perkin Elmer, Foster City, CA).
Western blot analysis
About 10 7 cells were pelleted by centrifugation, washed with PBS, and lysed with 50 µL of a lysis buffer containing protease inhibitors (20 mM HEPES, pH 7.5, 10 mM EGTA, 40 mM ␤-glycerophosphate, 1% NP-40, 2.5 mM MgCl 2 , 2 mM orthovanadate, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 20 µg/mL aprotinin, 20 µg/mL leupeptin). After 20 min on ice, solubilized proteins were obtained by centrifugation, boiled in Laemmli sample buffer (2% SDS, 10% glycerol, 140 mM ␤-mercaptoethanol, 60 mM Tris-HCl, pH 6.8, 0.01% bromophenol blue), and electrophoresed in SDS-polyacrylamide gels. Protein was measured with a Bio-Rad Protein Assay kit. Proteins (20 µg) were separated through 12% SDS-polyacrylamide gels under reducing conditions, transferred to nitrocellulose filters, and subjected to immunological detection. Pre-stained protein molecular mass standards (Bio-Rad) were also run in the same gel. After electrophoresis and blocking for 1 h in 3% powdered defatted milk in TBS buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl), the nitrocellulose filters were incubated overnight with the respective specific antibodies (dilution 1:1000 in TBS buffer containing 0.05% Tween 20): mouse monoclonal anti-caspase-2 antibody, rabbit polyclonal anti-caspase-3 antibody, and rabbit polyclonal anti-caspase-10 antibody. Filters were then incubated for 1 h with biotinylated anti-mouse IgG or anti-rabbit IgG (both diluted at 1:1000 in TBS buffer containing 0.05% Tween 20), followed by streptavidin-horseradish peroxidase conjugate (diluted 1:1000 in TBS buffer containing 0.05% Tween 20). Signals were developed using an enhanced chemiluminescence detection (ECL) system (Amersham, Buckinghamshire, UK).
RESULTS
Spontaneous apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells
Human neutrophils, isolated from peripheral blood, were immediately incubated at 37°C in RPMI 1640 culture medium containing 10% (v/v) heat-inactivated fetal calf serum for 0, 5, 9, 12, and 24 h in a humidified atmosphere of air/CO 2 (19/1). At these incubation times, cells were collected and analyzed for internucleosomal DNA degradation, a hallmark of apoptosis. As shown in Figure 1 , human neutrophils started to undergo apoptosis after 9-12 h incubation, increasing this apoptotic response with the incubation time. This time course of neutrophil spontaneous apoptosis is in agreement with previous reports [2, 4, 5, 30] . Figure 2 shows the distinct morphological stages of the human neutrophil apoptotic process upon incubation in complete culture medium as above. After 3-h incubation, a small vacuolation could be detected in the neutrophil cytoplasm (Fig. 2B) . After 9 h of incubation, numerous cytoplasmic vacuoles and initial chromatin condensation were observed (Fig. 2C) . Then, after 15 h of incubation, chromatin condensation is highly increased. Rounded or oval masses of dense chromatin are attached to each other by a single slender chromatin filament and some nuclei adopt a four-leaf clover appearance (Fig. 2D) . At this stage, some cells are devoid of nucleus and show large cytoplasmic vacuoles (Fig. 2D) . After 24 h of incubation, the proportion of apoptotic neutrophils devoid of nucleus and exhibiting large vacuoles was highly increased, whereas other neutrophils displayed highly condensed chromatin masses bound by fine chromatin filaments (Fig. 2E) . Apoptotic neutrophils became rounded and showed a very smooth surface.
It has been previously reported that the human promyelocytic HL-60 cell line induced to differentiate toward neutrophils subsequently die by apoptosis [28, 29, 40] . In this regard, we have found that induction of HL-60 cell differentiation toward neutrophils by treatment with 1.3% (v/v) DMSO is accompanied by the appearance of DNA internucleosomal degradation (Fig. 3A) . HL-60 cells started to undergo apoptosis after 4 days of DMSO treatment (Fig. 3A) , in agreement with previous estimates [28] . Undifferentiated HL-60 cells are proliferative CD71-positive and CD11b-negative cells that are unable to generate superoxide anion, and thereby to reduce NBT, whereas mature peripheral blood neutrophils are terminal non-proliferative CD71-negative and CD11b-positive cells with a high capacity to reduce NBT [28, 49] . We have used these parameters to monitor the differentiation process of HL-60 cells during DMSO treatment. As shown in Figure 3 and Figure 4 , Bcl-2 overexpression prevents apoptosis, but not differentiation, of DMSO-treated HL-60 cells
It has been previously shown that differentiation and apoptosis can be uncoupled by overexpression of bcl-2 [41, 50, 51] . In agreement with these reports, we have found that overexpression of bcl-2 by gene transfer prevented apoptosis triggered during neutrophil differentiation (Fig. 3B) , but it did not block the differentiation process induced by DMSO (Fig. 4) . We found that Bcl-2-transfected HL-60 cells, which expressed a fivefold increase in the endogenous level of Bcl-2 protein [41] , underwent even a more rapid and potent differentiation process toward cells sharing many features of neutrophils than control HL-60-Neo cells, as assessed by the cell surface expression of the CD11b leukocyte antigen (Fig. 4A ) and the respiratory burst activity, measured by NBT reduction (Fig. 4C) . In contrast, the inhibition of the proliferative capacity of HL-60 cells and the concomitant internalization of the cell-surface transferrin receptor (CD71 antigen) were somewhat slowed down in Bcl-2-transfected HL-60 cells (Fig. 4, B [19] [20] [21] [22] . Previous reports have indicated that neutrophils lack bcl-2 expression [36, 39] , and this could be related to their readiness to undergo spontaneous apoptosis. However, due to the redundancy in the biological actions of the bcl-2 family members, we have studied the expression of a wide panel of bcl-2 family genes in both human neutrophils and neutrophildifferentiating HL-60 cells through semiquantitative RT-PCR. We investigated whether the spontaneous apoptosis displayed by HL-60 neutrophils and mature peripheral blood neutrophils might reflect a characteristic and differential expression of survival and death-promoting genes. Undifferentiated HL-60 expressed bak, bik, bax, bad, bcl-2, bcl-x L , bcl-w, and bfl-1/A1 (Fig. 5) , assessed by subsequent cloning and sequencing. The nucleotide sequence of human bfl-1 [52] was 100% identical to that of human A1 [53] . Thus, we have used the term bfl-1/A1 or bfl-1, interchangeably, throughout this work to refer to this human gene. As shown in Figure 5A , differentiation of HL-60 cells toward neutrophils with DMSO resulted in changes in the expression of some bcl-2 family genes: (1) [54] . The primers used in this study for bcl-x expression were designed to amplify both the bcl-x L and the bcl-x s isoforms, giving the expected PCR-amplified fragments of 542 and 353 bp for bcl-x L and bcl-x s , respectively. Expression of bcl-x s in HL-60 cells was only detected after increasing the number of cycles (up to 40 cycles), although its expression level was much lower than that of bcl-x L (Fig. 5B) . It is interesting to note, we found that the pattern of expression of bcl-2 family genes in human mature peripheral blood neutrophils was very similar to that shown by HL-60 cells differentiated toward neutrophils after a 4-day DMSO treatment, with the exception of bax and bcl-x L (Fig. 5) . We have compared the relative level of expression of bcl-2 family members between human neutrophils and other human myeloid cell lines, such as undifferentiated acute myeloid leukemia HL-60 cells [29, 40, 28] and promyelocytic NB4 cells [55] . Human neutrophils did not express bik, bax, bcl-2, bcl-x L , and bcl-x s , but did express significant levels of bak, bad, bcl-w, and bfl-1, as assessed by RT-PCR and subsequent cloning and sequencing. It is worth noting the remarkably high expression of bfl-1/A1 in neutrophils when compared to other human myeloid cell lines. This characteristic high level of bfl-1 expression in human neutrophils correlated well with the potent induction of this gene during HL-60 neutrophil differentiation (Fig. 5) . bak was also abundantly expressed in peripheral blood neutrophils and correlated with its induction during HL-60 neutrophil differentiation (Fig. 5) . A quantitative analysis of the changes detected in the expression of the above bcl-2 family members during neutrophil differentiation of HL-60 cells is shown in Figure 6 . The levels of mRNA of bfl-1, bcl-w, and bak were increased about 6.5-, 3.3-and 3.1-fold, respectively, after a 4-day DMSO treatment, whereas those of bcl-2 and bik were drastically reduced (Fig. 6 ). The levels of bcl-x L , bad, and bax transcripts were slightly reduced during the DMSO treatment (Fig. 6 ).
Participation of caspases in differentiation-induced HL-60 apoptosis and in spontaneous peripheral blood neutrophil cell death
An increasing number of cysteine proteases that specifically cleave proteins after Asp residues, named caspases, are absolutely required for the accurate and limited proteolytic events that typify programmed cell death [23, 24] . Thus, it is reasonable to think that caspase activation must play a role in the apoptotic process that follows the HL-60 neutrophil differentiation process. As shown in Figure 7 , treatment of HL-60 cells with the caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone prevented the induction of apoptosis during HL-60 neutrophil differentiation, but did not affect the differentiation process of these cells, as assessed by the cell-surface expression of CD11b, a marker of myeloid differentiation [28] . As nonproliferating cells, freshly isolated peripheral blood human neutrophils were arrested in G 1 /G 0 cell cycle phase, but the appearance of cells with a DNA content less than G 1 /G 0 (hypodiploidy), characteristic of apoptotic cells, was observed upon incubation in serum-containing culture medium (Fig. 8) .
Incubation of peripheral blood mature neutrophils with z-Asp-2,6-dichlorobenzoyloxymethylketone blocked neutrophil spontaneous apoptosis, as assessed by flow cytometry (hypodiploidy) and morphological analysis (Fig. 8) . Thus, internucleosomal DNA degradation and the typical morphological features of apoptotic neutrophils were prevented by caspase inhibition (Fig. 8) .
mRNA expression of caspases in human neutrophils and during neutrophil differentiation of HL-60 cells (Fig. 9) , as assessed by subsequent cloning and sequencing. In the case of caspase-1, we found that the nucleotide sequence corresponded to the ICE␤ isoform [56] . Caspase-2 (ICH-1) is alternatively spliced into two distinct Ich-1 mRNA species that encode proteins with opposite effects on cell death [57] . One mRNA species encodes a protein product of 435 amino acids (ICH-1 L ), which acts as an inducer of programmed cell death, whereas the other mRNA species encodes a 312-amino-acid truncated version of ICH-1 L protein, named ICH-1 s , that acts as a negative regulator of apoptosis [57] . The primers used in this study for caspase-2 (ICH-1) expression were chosen to amplify both forms, giving expected sizes of 345 for Ich-1 L and 406 bp for Ich-1 s ; the size of the amplified fragment for Ich-1 s being higher due to the insertion of 61 nt in its mRNA sequence, which leads to a truncated version of ICH-1 L protein. As shown in Figure 9 , HL-60 cells mainly expressed the Ich-1 L isoform (caspase-2), and the Ich-1 s isoform was only detected when the number of cycles used in the PCR reaction was increased (Fig.  9B ). We were unable to detect expression of caspase-5 (ICE rel III, TY) and caspase-6 (Mch2) under semiquantitative RT-PCR conditions, using 20-25 cycles. Expression of caspase-5 and caspase-6 in HL-60 cells were only detected after two consecutive PCR reactions, where the first PCR product was used as a template DNA in the second PCR reaction (data not shown), indicating that these two caspases were expressed at very reduced levels in these cells. Differentiation of HL-60 cells toward neutrophils with DMSO resulted in changes in the pattern of caspase expression. Caspases 1 and 9 were upregulated; caspases 2, 3, and 10 were down-regulated; and the levels of expression of caspases 4, 7, and 8 were essentially unmodified during DMSO treatment (Fig. 9A) . We found by RT-PCR, and subsequent cloning and sequencing, that mature neutrophils expressed high levels of caspases 1, 4, 7, 8, and 9, and lower levels of caspases 3 and 10, whereas caspase-2 was essentially absent (Fig. 9B) . Like HL-60 cells, mature neutrophils hardly expressed caspase-5 and caspase-6, and a second consecutive PCR reaction, using the first PCR product as template DNA for the second PCR round, was required to detect their expression.
Changes in the level of mRNA expression of bcl-2 and caspase family genes during prolonged treatment of HL-60 cells with DMSO It has been classically considered that complete differentiation of HL-60 cells toward neutrophils occurred after a 7-day DMSO treatment. The apoptotic gene expression changes detected after the 4-day DMSO treatment of HL-60 cells (Figs. 5 and 9) were also observed after prolonged incubation times of HL-60 cells with DMSO. Thus, bik, bcl-2, caspase-2, caspase-3, and caspase-10 were down-regulated; bfl-1/A1, caspase-1, and caspase-9 were up-regulated; and expression of bax, bad, bcl-x L , caspase-4, caspase-7, and caspase-8 was essentially unmodified (Fig.  10) . However, some peculiarities were observed during prolonged incubation of HL-60 cells with DMSO. Expression of bak and bcl-w were up-regulated during the first 4 days of DMSO treatment (Figs. 5 and 10 ), but then their expression was down-regulated (Fig. 10A) . Overall, these data further support the notion that a 4-day DMSO treatment leads to a differentiation stage of HL-60 cells that shares many functional, biochemical, and gene expression features with mature neutrophils.
Fas and FasL mRNA expression in human neutrophils and during neutrophil differentiation of HL-60 cells
The Fas/FasL system plays a major role in the initiation of the apoptotic response. We found that undifferentiated HL-60 cells expressed fas, and its expression was largely increased during neutrophil differentiation (Fig. 11) . The level of expression of fas was very high in mature neutrophils and HL-60 neutrophils, cells committed to undergo spontaneous and rapid cell death, when compared to untreated HL-60 cells (Fig. 11) . FasL was also expressed, but at very low levels, in human neutrophils and in undifferentiated HL-60 cells; its level of expression being unmodified during the neutrophil differentiation process of HL-60 cells (Fig. 11) .
Caspase protein expression in human neutrophils and during neutrophil differentiation of HL-60 cells
Because caspases 2, 3, and 10 were down-regulated at the mRNA level during neutrophil differentiation of HL-60 cells (Figs. 9 and 10) , we analyzed whether these changes were reflected at the protein level. Caspase-3 and -10 protein levels, detected as 36-and 55-kDa bands, respectively, were decreased during HL-60 cell differentiation until achieving the corresponding protein levels found in peripheral blood neutrophils (Fig. 12) . The 48-kDa caspase-2 protein content was dramatically reduced after DMSO treatment of HL-60 cells, and was not detected in both HL-60-differentiated neutrophils and peripheral blood neutrophils (Fig. 12) . The above decreases in caspase protein content were not due to the proteolytic cleavage of caspases occurring during apoptosis because these changes were observed before the induction of apoptosis, triggered after a 4-day DMSO treatment. These results show a correlation between changes in both mRNA and protein levels of caspases during neutrophil differentiation. 
DISCUSSION
The results reported here indicate that the onset of apoptosis in neutrophil-differentiating HL-60 cells is correlated with the achievement of an apoptosis-related gene expression pattern similar to that constitutively expressed in mature neutrophils. Thus, HL-60 cells are a useful cell culture model to study molecular aspects of the human neutrophil spontaneous apoptosis. Figure 13 summarizes the results herein reported concerning the mRNA expression pattern of a wide number of apoptosis-related genes in human peripheral blood mature neutrophils as well as during neutrophil differentiation of the HL-60 cell line. HL-60 cells treated with DMSO for 4 days acquire most of the biochemical and functional characteristics of mature neutrophils, including their capacity to undergo spontaneous apoptosis, and show an apoptotic gene expression pattern very similar to that found in mature neutrophils. This suggests that the changes observed in the expression levels of several apoptosis-related genes during neutrophil differentiation of HL-60 cells can play a role in the acquisition of their capacity to undergo spontaneous apoptosis. Expression of mRNA bcl-2 in HL-60 cells was dramatically inhibited during the first 24-h DMSO treatment, time required to induce irreversibly HL-60 cells to differentiate toward neutrophils [58] . It is interesting that bfl-1/A1 expression was highly up-regulated during neutrophil differentiation of HL-60 cells. This is in agreement with a previous report showing an elevation of A1 mRNA level during neutrophil differentiation of the murine 32D cl3 cell line with G-CSF [59] . We have found that human peripheral blood neutrophils and HL-60 neutrophils, which undergo spontaneous apoptosis, are prominent in bfl-1/A1 expression, an antiapoptotic gene. The expression of apoptosis-accelerating genes, such as bax and bak, is widespread in different tissues [60, 61] , whereas the expression of apoptosis-blocking genes, such as bcl-x L and bfl-1/A1, is restricted in some tissues [52] [53] [54] , suggesting that the activity of proapoptotic genes may be regulated by death inhibitory genes. The present results indicate that human neutrophils express two anti-apoptotic genes, bfl-1/A1 and bcl-w, which may have an important role in the maintenance of the lifespan of neutrophils. bfl-1/A1 is the only known bcl-2 family member that is inducible by inflammatory cytokines [53] . Thus, it is tempting to speculate that the high expression of bfl-1/A1 found in human neutrophils could be related to a protective role in these cells during the inflammatory response. bfl-1/A1 mRNA has been reported to be up-regulated by agonists (G-CSF, LPS) that promote neutrophil survival [62] . Bfl-1/A1 is able to interact with Bax, Bak, and Bcl-2 [63] . We have found that mature neutrophils and neutrophil-differentiated HL-60 cells express high levels of bfl-1/A1 and bak, and lower levels of bad and bcl-w. It can be suggested that bfl-1/A1 and bak play a major role in regulating apoptosis in mature neutrophils because: (1) both genes are the bcl-2 family members most abundantly expressed in mature neutrophils; (2) they are strongly up-regulated during HL-60 neutrophil differentiation; and (3) both genes can form homodimers and heterodimers regulating the cell fate.
The importance of bcl-2 family genes in the differentiationinduced apoptosis in HL-60 cells is evidenced by the fact that overexpression of bcl-2 or bfl-1/A1 prevents apoptosis during myeloid differentiation [41, 50, 51, 64, this report]. We have found that bcl-2 overexpression accelerates DMSO-induced differentiation of HL-60 cells toward the neutrophil lineage; whereas it prevents completely differentiation-induced apoptosis. IL-3 withdrawal from bcl-2-transfected FDCP Mix cells has been reported to lead to differentiation, largely to neutrophils [65] . We have also found that the DMSO-induced inhibition of proliferation as well as the loss of CD71 antigen proceed sluggishly in Bcl-2-transfected HL-60 cells compared with The pattern of expression of fas and fasL in human peripheral blood PMN and human promyelocytic HL-60 cells was assessed by RT-PCR analysis. Total RNA was purified from these cells and subjected to RT-PCR analysis with oligonucleotide primers specific for each gene. PCR amplification of ␤-actin was used as an internal control. After 27 (fas) and 40 cycles (fasL), the PCR products were electrophoresed onto a 2% agarose gel and stained with ethidium bromide. Experiments shown are representative of three performed.
HL-60-Neo or untransfected HL-60 cells. In this regard, it has been reported that bcl-2-transfected cells may temporarily proliferate after growth factor removal [64, 66] , suggesting a link between Bcl-2 and cell cycle.
Involvement of caspase activation in neutrophil spontaneous apoptosis was evidenced by prevention of apoptosis in differentiating HL-60 cells and human peripheral blood neutrophils by the aspartate-based caspase inhibitor z-Asp-2,6-dichlorobenzoyloxymethylketone. Caspase expression patterns were well correlated between human neutrophils and HL-60 neutrophils. Caspase-3 and caspase-10 were down-regulated, both at mRNA and protein levels, during neutrophil HL-60 differentiation, until achieving the expression level of mature neutrophils. Caspase-2 was drastically down-regulated, both at mRNA and protein levels, during neutrophil differentiation, and was absent in peripheral blood neutrophils and HL-60 differentiated neutrophils. These results show a good correlation between mRNA and protein expression levels and suggests that caspase-2 does not play any role in neutrophil spontaneous apoptosis.
The present results indicate that human peripheral blood neutrophils express a characteristic pattern of apoptosis-related genes, which includes: initiation genes (fas and fasL), proapoptotic regulatory genes (bak and bad), anti-apoptotic regulatory genes (bfl-1/A1 and bcl-w), and executioner genes (caspases 1, 3, 4, 7, 8, 9, and 10). Thus, human neutrophils contain the complete machinery necessary to regulate their own programmed cell death. The Fas/FasL system has been reported to be of critical importance in the induction of mature neutrophil apoptosis [36] [37] [38] . Binding of FasL to Fas induces trimerization of Fas receptor that recruits caspase-8 via the FADD/MORT1 adaptor [67] , forming the death-inducing signaling complex (DISC). Recruitment of caspase-8 to the DISC leads to its proteolytic activation, which initiates a cascade of caspases, leading to apoptosis. HL-60 cells are resistant to Fas-mediated apoptosis [68, 69] , whereas mature neutrophils and neutrophildifferentiated HL-60 cells rapidly undergo apoptosis upon Fas activation [36-38, 40, 70] . This could be explained, in part, by the increase in fas expression during neutrophil differentiation of HL-60 cells and by the prominent expression of this gene in peripheral blood neutrophils reported here. On the other hand, it is interesting to note that human neutrophils express very high levels of c-jun mRNA [71] , a proto-oncogene involved in programmed cell death [72, 73] . Thus, human neutrophils show a wide expression pattern of genes involved in programmed cell death. We suggest that this expression pattern of apoptosisrelated genes in human neutrophils, distinct from other cell types, might be responsible for their peculiar spontaneous apoptosis. Neutrophil apoptosis showed two characteristic morphological features, namely: (1) rounded or oval masses of condensed chromatin attached to each other by slender chromatin filaments; (2) loss of nuclei and presence of large cytoplasmic vacuoles instead. Internucleosomal DNA fragmentation occurred after 9-12 h of incubation of mature neutrophils in serum-containing culture medium.
Apoptosis is mainly regulated by the ratio of cell death promoters/inhibitors, which will ultimately dictate the final outcome. As shown here, the expression pattern and the balance of apoptosis-related genes are very similar in both undifferentiated proliferating HL-60 and NB4 human leukemic cells, but differ from the gene expression pattern observed in terminal myeloid cells ready to undergo apoptosis (mature neutrophils and HL-60 neutrophils). It could be envisaged that some changes in gene expression can be of major importance to render HL-60 cells susceptible to undergoing apoptosis during DMSO-induced neutrophil differentiation, namely the downregulation of the anti-apoptotic bcl-2, and the up-regulation of fas and bak, which initiate and promote, respectively, programmed cell death. The results reported here suggest that the similar pattern of expression of survival and death-promoting genes shown in this study in both HL-60 neutrophils and peripheral blood mature neutrophils might lead to the characteristic and spontaneous apoptosis exhibited by these cell types.
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